PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15470067-7	2004	BK-induced ERK activation was inhibited by HOE140, manumycin A, GW 5074, and PD 098059.	glycyltryptophan	64-66	mitogen-activated protein kinase 1	Homo sapiens	11-14	
19717011-6	2009	Pretreatment of A549 cells with either manumycin A or GW 5074 attenuated YC-1-induced p44/42 MAPK activation.	glycyltryptophan	54-56	mitogen-activated protein kinase 1	Homo sapiens	93-97	
19717011-7	2009	The YC-1-mediated increase in IKKalpha/beta activation and kappaB-luciferase activity were attenuated by GW 5074, a MAPK/ERK kinase (MEK) inhibitor (PD 98059), and an ERK2 inhibitor (AG 126).	glycyltryptophan	105-107	mitogen-activated protein kinase 1	Homo sapiens	116-120	
19717011-7	2009	The YC-1-mediated increase in IKKalpha/beta activation and kappaB-luciferase activity were attenuated by GW 5074, a MAPK/ERK kinase (MEK) inhibitor (PD 98059), and an ERK2 inhibitor (AG 126).	glycyltryptophan	105-107	mitogen-activated protein kinase 1	Homo sapiens	167-171	
15277314-8	2004	Inhibition of Raf-1, mitogen-activated protein kinase kinase (MAPKK/MEK), p38 MAPK and STAT1 with, respectively, GW 5074, PD 98059, SB 203580 and epigallocatechin gallate prevented inhibition of Na(+)-K(+)-ATPase activity by IFN-gamma.	glycyltryptophan	113-115	mitogen-activated protein kinase 1	Homo sapiens	74-77